Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The inspection classification was determined by the agency as Voluntary Action Indicated
The cognitively operated system is a mother patent invention, first launched in India
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
This approval has come from the company's finished dosage form manufacturing facility
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
Subscribe To Our Newsletter & Stay Updated